Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
13 11 2023
Historique:
received: 13 06 2023
accepted: 04 10 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Severe weakness associated with critical illness (CIW) is common. This narrative review summarizes the latest scientific insights and proposes a guide for clinicians to optimize the diagnosis and management of the CIW during the various stages of the disease from the ICU to the community stage. CIW arises as diffuse, symmetrical weakness after ICU admission, which is an important differentiating factor from other diseases causing non-symmetrical muscle weakness or paralysis. In patients with adequate cognitive function, CIW can be easily diagnosed at the bedside using manual muscle testing, which should be routinely conducted until ICU discharge. In patients with delirium or coma or those with prolonged, severe weakness, specific neurophysiological investigations and, in selected cases, muscle biopsy are recommended. With these exams, CIW can be differentiated into critical illness polyneuropathy or myopathy, which often coexist. On the general ward, CIW is seen in patients with prolonged previous ICU treatment, or in those developing a new sepsis. Respiratory muscle weakness can cause neuromuscular respiratory failure, which needs prompt recognition and rapid treatment to avoid life-threatening situations. Active rehabilitation should be reassessed and tailored to the new patient's condition to reduce the risk of disease progression. CIW is associated with long-term physical, cognitive and mental impairments, which emphasizes the need for a multidisciplinary model of care. Follow-up clinics for patients surviving critical illness may serve this purpose by providing direct clinical support to patients, managing referrals to other specialists and general practitioners, and serving as a platform for research to describe the natural history of post-intensive care syndrome and to identify new therapeutic interventions. This surveillance should include an assessment of the activities of daily living, mood, and functional mobility. Finally, nutritional status should be longitudinally assessed in all ICU survivors and incorporated into a patient-centered nutritional approach guided by a dietician. Early ICU mobilization combined with the best evidence-based ICU practices can effectively reduce short-term weakness. Multi-professional collaborations are needed to guarantee a multi-dimensional evaluation and unitary community care programs for survivors of critical illnesses.

Sections du résumé

BACKGROUND
Severe weakness associated with critical illness (CIW) is common. This narrative review summarizes the latest scientific insights and proposes a guide for clinicians to optimize the diagnosis and management of the CIW during the various stages of the disease from the ICU to the community stage.
MAIN BODY
CIW arises as diffuse, symmetrical weakness after ICU admission, which is an important differentiating factor from other diseases causing non-symmetrical muscle weakness or paralysis. In patients with adequate cognitive function, CIW can be easily diagnosed at the bedside using manual muscle testing, which should be routinely conducted until ICU discharge. In patients with delirium or coma or those with prolonged, severe weakness, specific neurophysiological investigations and, in selected cases, muscle biopsy are recommended. With these exams, CIW can be differentiated into critical illness polyneuropathy or myopathy, which often coexist. On the general ward, CIW is seen in patients with prolonged previous ICU treatment, or in those developing a new sepsis. Respiratory muscle weakness can cause neuromuscular respiratory failure, which needs prompt recognition and rapid treatment to avoid life-threatening situations. Active rehabilitation should be reassessed and tailored to the new patient's condition to reduce the risk of disease progression. CIW is associated with long-term physical, cognitive and mental impairments, which emphasizes the need for a multidisciplinary model of care. Follow-up clinics for patients surviving critical illness may serve this purpose by providing direct clinical support to patients, managing referrals to other specialists and general practitioners, and serving as a platform for research to describe the natural history of post-intensive care syndrome and to identify new therapeutic interventions. This surveillance should include an assessment of the activities of daily living, mood, and functional mobility. Finally, nutritional status should be longitudinally assessed in all ICU survivors and incorporated into a patient-centered nutritional approach guided by a dietician.
CONCLUSIONS
Early ICU mobilization combined with the best evidence-based ICU practices can effectively reduce short-term weakness. Multi-professional collaborations are needed to guarantee a multi-dimensional evaluation and unitary community care programs for survivors of critical illnesses.

Identifiants

pubmed: 37957759
doi: 10.1186/s13054-023-04676-3
pii: 10.1186/s13054-023-04676-3
pmc: PMC10644573
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

439

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Crit Care Med. 2023 Oct 1;51(10):1373-1385
pubmed: 37246922
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1437-46
pubmed: 25496103
Lancet Respir Med. 2023 Jun;11(6):506-509
pubmed: 37187192
F1000Res. 2014 Jun 11;3:127
pubmed: 25309729
Crit Care. 2021 Apr 22;25(1):157
pubmed: 33888128
Intensive Care Med. 2015 Dec;41(12):2138-48
pubmed: 26266842
Ann Neurol. 1993 Jan;33(1):94-100
pubmed: 8388191
Intensive Care Med. 2020 Jun;46(6):1184-1193
pubmed: 31970446
Intensive Care Med. 2008 Mar;34(3):447-53
pubmed: 18046533
Intensive Care Med. 2015 Oct;41(10):1854-6
pubmed: 26160731
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
Crit Care Med. 2015 Aug;43(8):1603-11
pubmed: 25882765
Crit Care. 2021 Mar 17;25(1):108
pubmed: 33731201
Curr Opin Crit Care. 2010 Apr;16(2):123-7
pubmed: 20075723
Front Med (Lausanne). 2022 Jul 22;9:930262
pubmed: 35935791
Crit Care Med. 2021 Mar 1;49(3):e247-e257
pubmed: 33416257
Crit Care Med. 2014 Apr;42(4):849-59
pubmed: 24247473
Nat Med. 2022 Jun;28(6):1141-1148
pubmed: 35715504
Eur Respir Rev. 2023 Apr 5;32(168):
pubmed: 37019456
Lancet Respir Med. 2016 Jul;4(7):566-573
pubmed: 27155770
Am J Respir Crit Care Med. 2014 May 15;189(10):1214-24
pubmed: 24716641
J Neuropathol Exp Neurol. 1993 Jul;52(4):387-98
pubmed: 8355028
Lancet Respir Med. 2021 Nov;9(11):1328-1341
pubmed: 34678213
Thorax. 2021 Jun;76(6):561-567
pubmed: 33712505
J Intensive Care Med. 2023 Feb;38(2):151-159
pubmed: 35695208
Intensive Care Med. 2014 Apr;40(4):484-95
pubmed: 24522878
Clin Neurol Neurosurg. 1991;93(1):27-33
pubmed: 1651187
Crit Care. 2023 Jul 31;27(1):301
pubmed: 37525219
Ann Intensive Care. 2020 Jan 3;10(1):1
pubmed: 31900667
Am J Respir Crit Care Med. 2008 Aug 1;178(3):261-8
pubmed: 18511703
J Head Trauma Rehabil. 2018 Nov/Dec;33(6):424-434
pubmed: 30395042
Crit Care Med. 2019 Jan;47(1):3-14
pubmed: 30339549
Crit Care. 2023 Jan 3;27(1):2
pubmed: 36597123
Crit Care. 2016 Sep 27;20(1):301
pubmed: 27677709
N Engl J Med. 2023 Mar 9;388(10):913-924
pubmed: 36884324
Acta Anaesthesiol Scand. 2009 Jul;53(6):724-30
pubmed: 19388891
Neurocrit Care. 2023 Jun;38(3):584-590
pubmed: 37029315
Eur J Intern Med. 2021 Mar;85:92-97
pubmed: 33451890
Lancet. 2014 Dec 6;384(9959):2064-76
pubmed: 24767707
J Intensive Care Soc. 2022 Aug;23(3):253-263
pubmed: 36033253
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2298-2309
pubmed: 35851996
Front Endocrinol (Lausanne). 2023 Mar 28;14:1136796
pubmed: 37056668
Rev Bras Ter Intensiva. 2017 Oct-Dec;29(4):466-475
pubmed: 29236843
Medicina (Kaunas). 2023 Apr 27;59(5):
pubmed: 37241077
JAMA. 1995 Oct 18;274(15):1221-5
pubmed: 7563512
JAMA. 2002 Dec 11;288(22):2859-67
pubmed: 12472328
BMJ Open. 2021 Oct 4;11(10):e052214
pubmed: 34607869
Crit Care. 2007;11(1):R11
pubmed: 17254336
Thorax. 2022 Jan;77(1):22-30
pubmed: 34112703
Crit Care Med. 2003 Apr;31(4):1012-6
pubmed: 12682465
Intensive Care Med. 1999 Dec;25(12):1437-9
pubmed: 10660855
Intensive Care Med. 2019 Aug;45(8):1061-1071
pubmed: 31236639
Am J Kidney Dis. 2023 Mar;81(3):336-351
pubmed: 36332719
Am J Respir Crit Care Med. 2014 Aug 15;190(4):410-20
pubmed: 24825371
Am J Respir Crit Care Med. 2017 Jan 1;195(1):57-66
pubmed: 27310484
Crit Care Med. 2019 Apr;47(4):566-573
pubmed: 30664526
Ann Intern Med. 2021 Feb;174(2):167-174
pubmed: 33284680
Brain. 1987 Aug;110 ( Pt 4):819-41
pubmed: 3651796
Lancet. 1993 Jun 12;341(8859):1487-91
pubmed: 8099377
Crit Care. 2013 Oct 10;17(5):R229
pubmed: 24112540
Crit Care. 2020 Nov 4;24(1):637
pubmed: 33148301
JAMA Neurol. 2016 May 1;73(5):608
pubmed: 27018514
Intensive Care Med. 2021 Dec;47(12):1462-1471
pubmed: 34750648
Dysphagia. 2019 Aug;34(4):475-486
pubmed: 30684017
Crit Care. 2011;15(1):R43
pubmed: 21276225
PLoS One. 2013 Sep 30;8(9):e75696
pubmed: 24098716
Curr Opin Crit Care. 2005 Aug;11(4):381-90
pubmed: 16015120
Intensive Care Med. 2017 Sep;43(9):1270-1281
pubmed: 28289812
BMC Pulm Med. 2022 Dec 6;22(1):466
pubmed: 36474276
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1399-1412
pubmed: 32893974
Thorax. 2022 Mar;77(3):300-303
pubmed: 34588274
Nat Rev Neurol. 2021 Mar;17(3):135-156
pubmed: 33318675
J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):838-41
pubmed: 18339730
J Nutr Health Aging. 2009 Nov;13(9):782-8
pubmed: 19812868
J Crit Care. 2015 Oct;30(5):1151.e9-14
pubmed: 26211979
Intensive Care Med. 2023 Aug;49(8):1000-1004
pubmed: 37160829
Lancet. 2013 Jun 22;381(9884):2222
pubmed: 23791345
Intensive Care Med. 2016 Sep;42(9):1504-5
pubmed: 27334267
Crit Care Med. 2009 Oct;37(10 Suppl):S299-308
pubmed: 20046114
Lancet Neurol. 2011 Oct;10(10):931-41
pubmed: 21939902
Clin Neurol Neurosurg. 1985;87(1):17-22
pubmed: 3987137
Crit Care Med. 2021 Aug 1;49(8):1227-1240
pubmed: 34115639
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981
pubmed: 31161771
Clin Nutr. 2019 Jun;38(3):1215-1220
pubmed: 29778511
Chest. 2016 Oct;150(4):966-971
pubmed: 27312737
Sci Rep. 2023 Jan 19;13(1):1079
pubmed: 36658164
Crit Care. 2017 Oct 4;21(1):249
pubmed: 28978333
Crit Care Med. 2020 Nov;48(11):e1121-e1128
pubmed: 32947470
J Neurosurg. 1998 Apr;88(4):769-72
pubmed: 9525727
Front Med (Lausanne). 2022 Mar 10;9:814219
pubmed: 35372418
Lancet Respir Med. 2023 Jun;11(6):563-572
pubmed: 36693400
Ann Intern Med. 2010 Aug 3;153(3):204-5
pubmed: 20679565
Rev Bras Ter Intensiva. 2015 Jul-Sep;27(3):199-201
pubmed: 26376161
Crit Care Med. 2017 Mar;45(3):446-453
pubmed: 28067712
Crit Care Med. 2017 Dec;45(12):2061-2069
pubmed: 29023260
Eur J Gen Pract. 2023 Dec;29(1):2213476
pubmed: 37248989
Chest. 2017 Apr;151(4):898-907
pubmed: 27374948
Intensive Care Med. 2020 Apr;46(4):594-605
pubmed: 31938825
Curr Opin Crit Care. 2016 Aug;22(4):279-84
pubmed: 27327244
J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1223-31
pubmed: 6094735
Postgrad Med J. 2008 Jul;84(993):354-60
pubmed: 18716014
Arch Neurol. 2010 Sep;67(9):1089-94
pubmed: 20837853
N Engl J Med. 2022 Nov 10;387(19):1747-1758
pubmed: 36286256
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
Crit Care. 2015 Feb 26;19:52
pubmed: 25882719
Curr Opin Crit Care. 2023 Apr 1;29(2):75-84
pubmed: 36794932
Crit Care. 2019 Nov 21;23(1):368
pubmed: 31752979
Intensive Care Med. 1999 Nov;25(11):1302-6
pubmed: 10654218
Br Med J. 1947 Dec 13;2(4536):967
pubmed: 18897489
BMJ Open. 2023 May 22;13(5):e072448
pubmed: 37217272
Front Med (Lausanne). 2020 Nov 23;7:559789
pubmed: 33330523
Crit Care. 2022 Sep 8;26(1):270
pubmed: 36076215
Crit Care. 2019 Mar 28;23(1):103
pubmed: 30922363
J Am Geriatr Soc. 2012 Jun;60(6):1070-7
pubmed: 22642542
Lancet. 1996 Jun 8;347(9015):1579-82
pubmed: 8667865

Auteurs

Nicola Latronico (N)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy. nicola.latronico@unibs.it.
Department of Emergency, ASST Spedali Civili University Hospital, Piazzale Ospedali Civili, 1, 25123, Brescia, Italy. nicola.latronico@unibs.it.
"Alessandra Bono" Interdepartmental University Research Center On Long-Term Outcome (LOTO) in Critical Illness Survivors, University of Brescia, Brescia, Italy. nicola.latronico@unibs.it.

Frank A Rasulo (FA)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Department of Emergency, ASST Spedali Civili University Hospital, Piazzale Ospedali Civili, 1, 25123, Brescia, Italy.
"Alessandra Bono" Interdepartmental University Research Center On Long-Term Outcome (LOTO) in Critical Illness Survivors, University of Brescia, Brescia, Italy.

Matthias Eikermann (M)

Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Simone Piva (S)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Department of Emergency, ASST Spedali Civili University Hospital, Piazzale Ospedali Civili, 1, 25123, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH